×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Mersana Therapeutics, Inc. (MRSN) NASDAQ

$1.77 - (-)

Market Cap: $217.13M

As of 09/12/24 04:00 PM EDT. Market closed.

(MRSN)

Mersana Therapeutics, Inc. (MRSN)
NASDAQ

$1.77
- (-)

Market Cap: $217.13M

As of 09/12/24 04:00 PM EDT. Market closed.

Add to Portfolio

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC ... read more

COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Martin H. Huber M.D.
Full Time Employees
123
CEO Compensation (Base)
$194,311
CEO Compensation (Total)
$2.60M
URL
Address
840 Memorial Drive, MA, Cambridge, 02139.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Martin H. Huber M.D.
Full Time Employees
123
CEO Compensation (Base)
$194,311
CEO Compensation (Total)
$2.60M
Address
840 Memorial Drive, MA, Cambridge, 02139.
PRICE CHART FOR MERSANA THERAPEUTICS, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.80
Previous Close
$1.77
Days Range
$1.73 - $1.84
52 week range
$1.07 - $6.28
Volume
940,753
Avg. Volume (30 days)
1,242,001
Market Cap
$217.13M
Dividend Yield
-
P/E
(2.08)
Shares Outstanding
122,675,000
Open
$1.80
Previous Close
$1.77
Days Range
$1.73 - $1.84
52 week range
$1.07 - $6.28
Volume
940,753
Avg. Volume (30 days)
1,242,001
Market Cap
$217.13M
Dividend Yield
-
P/E
(2.08)
Shares Outstanding
122,675,000
FINANCIAL STATEMENTS FOR MERSANA THERAPEUTICS, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MERSANA THERAPEUTICS, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Protopapas AnnaDirectorJan 16, 2024 Sale$2.7129,39979,671125,153Jan 17, 2024, 05:21 PM
MISRA TUSHARSVP, Chief Manuf. OfficerJan 16, 2024 Sale$2.713,3579,09717,966Jan 17, 2024, 05:21 PM
Mandelia AshishVP, Chief Accounting OfficerJan 16, 2024 Sale$2.715,02513,61823,328Jan 17, 2024, 05:20 PM
Lowinger Timothy BSVP, Chief Sci.&Tech. OfficerJan 16, 2024 Sale$2.7110,40928,208199,329Jan 17, 2024, 05:19 PM
Carvajal AlejandraSVP, Chief Legal OfficerJan 16, 2024 Sale$2.714,38111,87327,403Jan 17, 2024, 05:18 PM
DeSchuytner BrianSVP, COO & CFOJan 16, 2024 Sale$2.719,32725,27654,511Jan 17, 2024, 05:18 PM
Bala MohanSVP, Chief Development OfficerJan 16, 2024 Sale$2.713,4319,29814,052Jan 17, 2024, 05:16 PM
Bala MohanSVP, Chief Development OfficerOct 26, 2023 Sale$1.131,9122,1618,733Oct 27, 2023, 04:07 PM
MISRA TUSHARSVP, Chief Manuf. OfficerAug 17, 2023 Sale$1.181,9082,25111,507Aug 18, 2023, 04:01 PM
Carvajal AlejandraSVP, Chief Legal OfficerApr 27, 2023 Sale$3.893,94415,34220,326Apr 28, 2023, 04:15 PM
Yang ArvinSVP, Chief Medical OfficerJan 17, 2023 Sale$5.742,20912,68030,821Jan 18, 2023, 08:29 PM
Protopapas AnnaPresident & CEOJan 17, 2023 Sale$5.7417,34699,56648,733Jan 18, 2023, 08:24 PM
Mandelia AshishVP, ControllerJan 17, 2023 Sale$5.743,57520,52013,619Jan 18, 2023, 08:20 PM
MISRA TUSHARSVP, CMOJan 17, 2023 Sale$5.744582,6295,930Jan 18, 2023, 08:18 PM
Lowinger Timothy BSVP, Chief Sci.&Tech. Off.Jan 17, 2023 Sale$5.746,23335,777180,363Jan 18, 2023, 08:14 PM
DeSchuytner BrianSVP, Chief Financial OfficerJan 17, 2023 Sale$5.745,13129,45232,781Jan 18, 2023, 08:12 PM
Carvajal AlejandraSVP, Chief Legal OfficerJan 17, 2023 Sale$5.747824,48911,020Jan 18, 2023, 08:09 PM
Lowinger Timothy BSVP, Chief Sci.&Tech. Off.Dec 14, 2022 Option Exercise$1.4935,36152,658166,595Dec 16, 2022, 04:46 PM
Yang ArvinChief Medical OfficerDec 01, 2022 Sale$6.595,52736,42325,946Dec 02, 2022, 04:01 PM
MISRA TUSHARChief Manufacturing OfficerAug 17, 2022 Sale$7.101,87913,3414,371Aug 18, 2022, 04:40 PM
Hack Andrew A. F.DirectorJun 02, 2022 Buy$3.2014,76047,1828,663,673Jun 02, 2022, 06:17 PM
Hack Andrew A. F.DirectorMay 31, 2022 Buy$3.2880,759264,7768,648,913Jun 02, 2022, 06:17 PM
Hack Andrew A. F.DirectorMay 25, 2022 Buy$3.1790,155286,2428,493,154May 26, 2022, 06:02 PM
Hack Andrew A. F.DirectorMay 24, 2022 Buy$3.29100,000328,9908,402,999May 26, 2022, 06:02 PM
Hack Andrew A. F.DirectorMay 26, 2022 Buy$3.1975,000238,9428,568,154May 26, 2022, 06:02 PM
Hack Andrew A. F.DirectorMay 23, 2022 Buy$3.3515,59952,2478,302,999May 23, 2022, 05:49 PM
Hack Andrew A. F.DirectorMay 20, 2022 Buy$3.46100,000345,5708,287,400May 23, 2022, 05:49 PM
Hack Andrew A. F.DirectorMay 19, 2022 Buy$3.49100,000348,6208,187,400May 23, 2022, 05:49 PM
Hack Andrew A. F.DirectorMay 16, 2022 Buy$3.10135,292419,4467,872,692May 18, 2022, 06:19 PM
Hack Andrew A. F.DirectorMay 18, 2022 Buy$3.35211,268707,2628,087,400May 18, 2022, 06:19 PM
Hack Andrew A. F.DirectorMay 17, 2022 Buy$3.183,44010,9527,876,132May 18, 2022, 06:19 PM
Carvajal AlejandraChief Legal OfficerApr 26, 2022 Sale$3.693,94814,5689,302Apr 28, 2022, 05:23 PM
Hack Andrew A. F.DirectorApr 13, 2022 Buy$4.05617,2842,500,0007,737,400Apr 14, 2022, 04:59 PM
Hack Andrew A. F.DirectorApr 12, 2022 Buy$4.18598,0862,499,8807,120,116Apr 13, 2022, 06:27 PM
Hack Andrew A. F.DirectorFeb 07, 2022 Buy$4.421,136,3635,022,7256,522,030Feb 08, 2022, 05:04 PM
Lowinger Timothy BChief Science & Tech Off.Jan 18, 2022 Sale$5.924,74128,067131,234Jan 19, 2022, 06:25 PM
Mandelia AshishVP, ControllerJan 18, 2022 Sale$5.921,98211,7333,371Jan 19, 2022, 06:19 PM
Hack Andrew A. F.DirectorDec 29, 2021 Buy$5.75875,0005,031,2504,570,667Jan 03, 2022, 06:28 PM
Lowinger Timothy BChief Science & Tech. OfficerDec 20, 2021 Option Exercise$1.4045,59363,830120,766Dec 20, 2021, 05:01 PM
Yang ArvinChief Medical OfficerDec 01, 2021 Sale$6.815,52737,63912,973Dec 02, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerAug 20, 2021 Option Exercise$6.162,21613,65177,389Aug 24, 2021, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerAug 20, 2021 Sale$11.012,21624,39875,173Aug 24, 2021, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerJul 20, 2021 Option Exercise$6.162,22713,71877,400Jul 22, 2021, 04:32 PM
Lowinger Timothy BChief Science & Tech. OfficerJul 20, 2021 Sale$12.112,22726,96975,173Jul 22, 2021, 04:32 PM
Lowinger Timothy BChief Science & Tech. OfficerJul 16, 2021 Sale$12.477,77596,95483,669Jul 19, 2021, 08:50 PM
Lowinger Timothy BChief Science & Tech. OfficerJul 19, 2021 Sale$12.028,496102,12275,173Jul 19, 2021, 08:50 PM
Kaufman Michael J.Chief Manufacturing OfficerJul 19, 2021 Sale$12.026,31275,87032,622Jul 19, 2021, 08:50 PM
Kaufman Michael J.Chief Manufacturing OfficerJul 16, 2021 Sale$12.475,77672,02738,934Jul 19, 2021, 08:50 PM
Protopapas AnnaPresident & CEOJul 19, 2021 Sale$12.0221,901263,250282,978Jul 19, 2021, 08:49 PM
Protopapas AnnaPresident & CEOJul 16, 2021 Sale$12.4720,043249,936304,879Jul 19, 2021, 08:49 PM
Lowinger Timothy BCS & Technology OfficerJul 08, 2021 Option Exercise$1.4020,00028,00051,444Jul 09, 2021, 05:25 PM
Lowinger Timothy BCS & Technology OfficerJul 01, 2021 Option Exercise$3.521,8866,64433,330Jul 02, 2021, 04:32 PM
Lowinger Timothy BCS & Technology OfficerJul 01, 2021 Sale$13.601,88625,65031,444Jul 02, 2021, 04:32 PM
Mandelia AshishVP, ControllerJul 01, 2021 Sale$13.6094212,8110Jul 02, 2021, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerJun 21, 2021 Option Exercise$6.162,22013,67033,662Jun 23, 2021, 04:30 PM
Lowinger Timothy BChief Science & Tech. OfficerJun 21, 2021 Sale$13.782,22030,59231,444Jun 23, 2021, 04:30 PM
Alleva Lawrence MDirectorJun 01, 2021 Buy$14.381,03514,8832,120Jun 03, 2021, 06:58 PM
Lowinger Timothy BChief Science & Tech. OfficerApr 20, 2021 Option Exercise$4.954,10220,30033,671Apr 22, 2021, 04:16 PM
Lowinger Timothy BChief Science & Tech. OfficerApr 20, 2021 Sale$15.914,10265,26331,444Apr 22, 2021, 04:16 PM
Lowinger Timothy BChief Science & Tech. OfficerMar 22, 2021 Option Exercise$4.958,20340,59633,671Mar 24, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerMar 22, 2021 Sale$17.508,203143,55331,444Mar 24, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerFeb 22, 2021 Option Exercise$4.958,20340,59633,671Feb 24, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerFeb 22, 2021 Sale$20.018,203164,14231,444Feb 24, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerJan 20, 2021 Option Exercise$4.958,20340,59633,671Jan 22, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerJan 20, 2021 Sale$21.548,203176,69331,444Jan 22, 2021, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerJan 15, 2021 Option Exercise$21.092,32449,01331,444Jan 20, 2021, 07:05 PM
Kaufman Michael J.Sr VP, Chemistry, Man.&ControlJan 15, 2021 Option Exercise$21.091,95741,2734,710Jan 20, 2021, 07:04 PM
DeSchuytner BrianSr. VP., FIN, Product StrategyJan 15, 2021 Option Exercise$21.091,16224,5076,423Jan 20, 2021, 07:04 PM
Protopapas AnnaPresident & CEOJan 15, 2021 Option Exercise$21.095,198109,626224,922Jan 20, 2021, 07:04 PM
Mandelia AshishVP, ControllerJan 15, 2021 Option Exercise$21.092896,095545Jan 20, 2021, 07:03 PM
Mandelia AshishVP, ControllerJan 19, 2021 Sale$21.2854511,5980Jan 20, 2021, 07:03 PM
Hack Andrew A. F.DirectorJan 08, 2021 Buy$18.39100,0001,839,0003,545,667Jan 12, 2021, 07:29 PM
Hack Andrew A. F.DirectorJan 12, 2021 Buy$18.1675,0001,362,0003,695,667Jan 12, 2021, 07:29 PM
Hack Andrew A. F.DirectorJan 11, 2021 Buy$18.5275,0001,389,0003,620,667Jan 12, 2021, 07:29 PM
Mandelia AshishVP, ControllerJan 04, 2021 Sale$26.762476,6100Jan 06, 2021, 07:00 PM
Lowinger Timothy BChief Science & Tech. OfficerDec 28, 2020 Option Exercise$1.409,00012,60025,851Dec 30, 2020, 05:00 PM
Lowinger Timothy BChief Science & Tech. OfficerDec 21, 2020 Option Exercise$4.958,20340,5962,227Dec 22, 2020, 04:34 PM
Lowinger Timothy BChief Science & Tech. OfficerDec 21, 2020 Sale$25.608,203209,9560Dec 22, 2020, 04:34 PM
Lowinger Timothy BChief Science & Tech. OfficerNov 20, 2020 Option Exercise$4.958,20340,5962,227Nov 24, 2020, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerNov 20, 2020 Sale$23.058,203189,0790Nov 24, 2020, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerOct 21, 2020 Option Exercise$4.954,10120,29619,078Oct 22, 2020, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerOct 20, 2020 Option Exercise$2.5620,95353,60516,851Oct 22, 2020, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerOct 21, 2020 Sale$17.504,10171,76816,851Oct 22, 2020, 04:31 PM
Lowinger Timothy BChief Science & Tech. OfficerOct 20, 2020 Sale$16.744,10268,6670Oct 22, 2020, 04:31 PM
Lowinger Timothy BChief Science, Tech. OfficerSep 21, 2020 Option Exercise$4.958,20340,59616,865Sep 23, 2020, 04:30 PM
Lowinger Timothy BChief Science, Tech. OfficerSep 21, 2020 Sale$20.6620,614425,83212,411Sep 23, 2020, 04:30 PM
Jack Eva M.Chief Bus. Officer, Tres, Sec.Sep 14, 2020 Option Exercise$1.5335,24853,92935,248Sep 16, 2020, 06:31 PM
Jack Eva M.Chief Bus. Officer, Tres, Sec.Sep 14, 2020 Sale$22.0035,248775,4560Sep 16, 2020, 06:31 PM
Mandelia AshishVP, ControllerJun 30, 2020 Buy$4.873,38316,4753,383Jul 06, 2020, 04:15 PM
Mandelia AshishVP, ControllerJul 02, 2020 Sale$22.493,38376,0840Jul 06, 2020, 04:15 PM
Alleva Lawrence MDirectorJun 01, 2020 Buy$22.951,08524,9011,085Jun 03, 2020, 05:30 PM
SANDELL SCOTT D10% OwnerApr 14, 2020 Sale$9.222742,5260Apr 14, 2020, 05:54 PM
SANDELL SCOTT D10% OwnerApr 13, 2020 Sale$8.981,65014,8120Apr 14, 2020, 05:54 PM
SANDELL SCOTT D10% OwnerApr 14, 2020 Sale$9.222742,5260Apr 14, 2020, 05:54 PM
BASKETT FOREST10% OwnerApr 13, 2020 Sale$8.583,19027,3580Apr 14, 2020, 05:54 PM
SANDELL SCOTT D10% OwnerApr 13, 2020 Sale$8.5020,914177,7750Apr 13, 2020, 09:10 PM
Florence Anthony A. Jr.10% OwnerApr 13, 2020 Sale$8.5020,914177,7750Apr 13, 2020, 09:06 PM
BASKETT FOREST10% OwnerApr 13, 2020 Sale$8.5020,914177,7750Apr 13, 2020, 09:06 PM
New Enterprise Associates 14, L.P.10% OwnerAug 28, 2019 Sale$2.911,2113,52411,959,520Apr 13, 2020, 08:39 PM
New Enterprise Associates 14, L.P.10% OwnerAug 28, 2019 Option Exercise$0.0570,5933,53011,960,731Apr 13, 2020, 08:39 PM
Hack Andrew A. F.DirectorApr 07, 2020 Buy$5.993,445,66720,649,4633,445,667Apr 09, 2020, 04:11 PM
MOTT DAVID MDirectorApr 07, 2020 Buy$5.59538,5993,010,768538,599Apr 09, 2020, 03:31 PM
MOTT DAVID MDirectorMar 05, 2019 Buy$4.003,750,00015,000,00011,890,138Mar 06, 2019, 04:39 PM
New Enterprise Associates 14, L.P.10% OwnerMar 05, 2019 Buy$4.003,750,00015,000,00011,890,138Mar 06, 2019, 04:38 PM
Lowinger Timothy BChief Scientific OfficerSep 24, 2018 Option Exercise$1.403,5004,90015,991Sep 25, 2018, 05:07 PM
Lowinger Timothy BChief Scientific OfficerSep 24, 2018 Sale$11.633,50040,70512,491Sep 25, 2018, 05:07 PM
Lowinger Timothy BChief Scientific OfficerAug 27, 2018 Option Exercise$7.433,50026,00515,991Aug 29, 2018, 04:24 PM
Lowinger Timothy BChief Scientific OfficerAug 27, 2018 Sale$13.153,50046,02512,491Aug 29, 2018, 04:24 PM
Lowinger Timothy BChief Scientific OfficerJul 23, 2018 Sale$11.063,50038,71012,491Jul 25, 2018, 04:04 PM
Lowinger Timothy BChief Scientific OfficerJul 03, 2018 Option Exercise$1.4010,00014,00015,991Jul 05, 2018, 06:59 PM
Lowinger Timothy BChief Scientific OfficerFeb 21, 2018 Option Exercise$6.985,91141,2595,911Feb 23, 2018, 04:01 PM
Foster WayneVice President of FinanceJan 30, 2018 Option Exercise$3.0314,70544,58271,083Feb 01, 2018, 04:01 PM
Protopapas AnnaPresident and CEODec 20, 2017 Option Exercise$1.5310,41715,938130,719Dec 21, 2017, 04:06 PM
Viswanathan Ravi10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:20 PM
Sonsini Peter W.10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:19 PM
SANDELL SCOTT D10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:19 PM
MOTT DAVID MDirectorJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:18 PM
KERINS PATRICK J10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:18 PM
Florence Anthony A. Jr.10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:17 PM
BASKETT FOREST10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:17 PM
BARRIS PETER J10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:16 PM
BARRETT M JAMES10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:16 PM
New Enterprise Associates 14, L.P.10% OwnerJul 03, 2017 Buy$15.001,000,00015,000,0008,140,138Jul 06, 2017, 05:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Protopapas AnnaDirector01/16/202479,671
MISRA TUSHARSVP, Chief Manuf. Officer01/16/20249,097
Mandelia AshishVP, Chief Accounting Officer01/16/202413,618
Lowinger Timothy BSVP, Chief Sci.&Tech. Officer01/16/202428,208
Carvajal AlejandraSVP, Chief Legal Officer01/16/202411,873
DeSchuytner BrianSVP, COO & CFO01/16/202425,276
Bala MohanSVP, Chief Development Officer01/16/20249,298
Bala MohanSVP, Chief Development Officer10/26/20232,161
MISRA TUSHARSVP, Chief Manuf. Officer08/17/20232,251
Carvajal AlejandraSVP, Chief Legal Officer04/27/202315,342
Yang ArvinSVP, Chief Medical Officer01/17/202312,680
Protopapas AnnaPresident & CEO01/17/202399,566
Mandelia AshishVP, Controller01/17/202320,520
MISRA TUSHARSVP, CMO01/17/20232,629
Lowinger Timothy BSVP, Chief Sci.&Tech. Off.01/17/202335,777
DeSchuytner BrianSVP, Chief Financial Officer01/17/202329,452
Carvajal AlejandraSVP, Chief Legal Officer01/17/20234,489
Lowinger Timothy BSVP, Chief Sci.&Tech. Off.12/14/202252,658
Yang ArvinChief Medical Officer12/01/202236,423
MISRA TUSHARChief Manufacturing Officer08/17/202213,341
Hack Andrew A. F.Director06/02/202247,182
Hack Andrew A. F.Director05/31/2022264,776
Hack Andrew A. F.Director05/25/2022286,242
Hack Andrew A. F.Director05/24/2022328,990
Hack Andrew A. F.Director05/26/2022238,942
Hack Andrew A. F.Director05/23/202252,247
Hack Andrew A. F.Director05/20/2022345,570
Hack Andrew A. F.Director05/19/2022348,620
Hack Andrew A. F.Director05/16/2022419,446
Hack Andrew A. F.Director05/18/2022707,262
Hack Andrew A. F.Director05/17/202210,952
Carvajal AlejandraChief Legal Officer04/26/202214,568
Hack Andrew A. F.Director04/13/20222,500,000
Hack Andrew A. F.Director04/12/20222,499,880
Hack Andrew A. F.Director02/07/20225,022,725
Lowinger Timothy BChief Science & Tech Off.01/18/202228,067
Mandelia AshishVP, Controller01/18/202211,733
Hack Andrew A. F.Director12/29/20215,031,250
Lowinger Timothy BChief Science & Tech. Officer12/20/202163,830
Yang ArvinChief Medical Officer12/01/202137,639
Lowinger Timothy BChief Science & Tech. Officer08/20/202113,651
Lowinger Timothy BChief Science & Tech. Officer08/20/202124,398
Lowinger Timothy BChief Science & Tech. Officer07/20/202113,718
Lowinger Timothy BChief Science & Tech. Officer07/20/202126,969
Lowinger Timothy BChief Science & Tech. Officer07/16/202196,954
Lowinger Timothy BChief Science & Tech. Officer07/19/2021102,122
Kaufman Michael J.Chief Manufacturing Officer07/19/202175,870
Kaufman Michael J.Chief Manufacturing Officer07/16/202172,027
Protopapas AnnaPresident & CEO07/19/2021263,250
Protopapas AnnaPresident & CEO07/16/2021249,936
Lowinger Timothy BCS & Technology Officer07/08/202128,000
Lowinger Timothy BCS & Technology Officer07/01/20216,644
Lowinger Timothy BCS & Technology Officer07/01/202125,650
Mandelia AshishVP, Controller07/01/202112,811
Lowinger Timothy BChief Science & Tech. Officer06/21/202113,670
Lowinger Timothy BChief Science & Tech. Officer06/21/202130,592
Alleva Lawrence MDirector06/01/202114,883
Lowinger Timothy BChief Science & Tech. Officer04/20/202120,300
Lowinger Timothy BChief Science & Tech. Officer04/20/202165,263
Lowinger Timothy BChief Science & Tech. Officer03/22/202140,596
Lowinger Timothy BChief Science & Tech. Officer03/22/2021143,553
Lowinger Timothy BChief Science & Tech. Officer02/22/202140,596
Lowinger Timothy BChief Science & Tech. Officer02/22/2021164,142
Lowinger Timothy BChief Science & Tech. Officer01/20/202140,596
Lowinger Timothy BChief Science & Tech. Officer01/20/2021176,693
Lowinger Timothy BChief Science & Tech. Officer01/15/202149,013
Kaufman Michael J.Sr VP, Chemistry, Man.&Control01/15/202141,273
DeSchuytner BrianSr. VP., FIN, Product Strategy01/15/202124,507
Protopapas AnnaPresident & CEO01/15/2021109,626
Mandelia AshishVP, Controller01/15/20216,095
Mandelia AshishVP, Controller01/19/202111,598
Hack Andrew A. F.Director01/08/20211,839,000
Hack Andrew A. F.Director01/12/20211,362,000
Hack Andrew A. F.Director01/11/20211,389,000
Mandelia AshishVP, Controller01/04/20216,610
Lowinger Timothy BChief Science & Tech. Officer12/28/202012,600
Lowinger Timothy BChief Science & Tech. Officer12/21/202040,596
Lowinger Timothy BChief Science & Tech. Officer12/21/2020209,956
Lowinger Timothy BChief Science & Tech. Officer11/20/202040,596
Lowinger Timothy BChief Science & Tech. Officer11/20/2020189,079
Lowinger Timothy BChief Science & Tech. Officer10/21/202020,296
Lowinger Timothy BChief Science & Tech. Officer10/20/202053,605
Lowinger Timothy BChief Science & Tech. Officer10/21/202071,768
Lowinger Timothy BChief Science & Tech. Officer10/20/202068,667
Lowinger Timothy BChief Science, Tech. Officer09/21/202040,596
Lowinger Timothy BChief Science, Tech. Officer09/21/2020425,832
Jack Eva M.Chief Bus. Officer, Tres, Sec.09/14/202053,929
Jack Eva M.Chief Bus. Officer, Tres, Sec.09/14/2020775,456
Mandelia AshishVP, Controller06/30/202016,475
Mandelia AshishVP, Controller07/02/202076,084
Alleva Lawrence MDirector06/01/202024,901
SANDELL SCOTT D10% Owner04/14/20202,526
SANDELL SCOTT D10% Owner04/13/202014,812
SANDELL SCOTT D10% Owner04/14/20202,526
BASKETT FOREST10% Owner04/13/202027,358
SANDELL SCOTT D10% Owner04/13/2020177,775
Florence Anthony A. Jr.10% Owner04/13/2020177,775
BASKETT FOREST10% Owner04/13/2020177,775
New Enterprise Associates 14, L.P.10% Owner08/28/20193,524
New Enterprise Associates 14, L.P.10% Owner08/28/20193,530
Hack Andrew A. F.Director04/07/202020,649,463
MOTT DAVID MDirector04/07/20203,010,768
MOTT DAVID MDirector03/05/201915,000,000
New Enterprise Associates 14, L.P.10% Owner03/05/201915,000,000
Lowinger Timothy BChief Scientific Officer09/24/20184,900
Lowinger Timothy BChief Scientific Officer09/24/201840,705
Lowinger Timothy BChief Scientific Officer08/27/201826,005
Lowinger Timothy BChief Scientific Officer08/27/201846,025
Lowinger Timothy BChief Scientific Officer07/23/201838,710
Lowinger Timothy BChief Scientific Officer07/03/201814,000
Lowinger Timothy BChief Scientific Officer02/21/201841,259
Foster WayneVice President of Finance01/30/201844,582
Protopapas AnnaPresident and CEO12/20/201715,938
Viswanathan Ravi10% Owner07/03/201715,000,000
Sonsini Peter W.10% Owner07/03/201715,000,000
SANDELL SCOTT D10% Owner07/03/201715,000,000
MOTT DAVID MDirector07/03/201715,000,000
KERINS PATRICK J10% Owner07/03/201715,000,000
Florence Anthony A. Jr.10% Owner07/03/201715,000,000
BASKETT FOREST10% Owner07/03/201715,000,000
BARRIS PETER J10% Owner07/03/201715,000,000
BARRETT M JAMES10% Owner07/03/201715,000,000
New Enterprise Associates 14, L.P.10% Owner07/03/201715,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MERSANA THERAPEUTICS, INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.8,383,9100.00038%3.56%Other
BALYASNY ASSET MANAGEMENT L.P.3,655,9980.03%ExitedEvent Driven
GEODE CAPITAL MANAGEMENT, LLC2,493,4230.00044%5.73%Other
D. E. SHAW & CO., INC.1,465,5800.00276%19.87%Other
RENAISSANCE TECHNOLOGIES LLC1,448,2190.00494%1.43%Other
BAKER BROS. ADVISORS LP1,086,1150.03%No changeOther
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)544,2930.07%25.33%Value
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)57,4780.00448%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR MERSANA THERAPEUTICS, INC.
STOCK BUYBACKS FOR MERSANA THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.63%
1Q
03/31/2024
09/30/2023
0.75%
2Q
03/31/2024
06/30/2023
5.03%
3Q
03/31/2024
03/31/2023
12.94%
4Q
03/31/2024
12/31/2022
20.11%
5Q
03/31/2024
09/30/2022
24.36%
6Q
03/31/2024
06/30/2022
26.81%
7Q
03/31/2024
03/31/2022
51.92%
8Q
03/31/2024
12/31/2021
68.80%
9Q
03/31/2024
09/30/2021
69.23%
10Q
03/31/2024
06/30/2021
74.42%
11Q
03/31/2024
03/31/2021
76.01%
12Q
03/31/2024
12/31/2020
76.79%
13Q
03/31/2024
09/30/2020
77.47%
14Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.63%
1Q
09/30/2023
0.75%
2Q
06/30/2023
5.03%
3Q
03/31/2023
12.94%
4Q
12/31/2022
20.11%
5Q
09/30/2022
24.36%
6Q
06/30/2022
26.81%
7Q
03/31/2022
51.92%
8Q
12/31/2021
68.80%
9Q
09/30/2021
69.23%
10Q
06/30/2021
74.42%
11Q
03/31/2021
76.01%
12Q
12/31/2020
76.79%
13Q
09/30/2020
77.47%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MERSANA THERAPEUTICS, INC.
LOADING...